Medtronic (NYSE:MDT) Upgraded by Citigroup to “Buy” Rating
Citigroup upgraded shares of Medtronic (NYSE:MDT – Free Report) from a neutral rating to a buy rating in a research report released on Tuesday morning, MarketBeat.com reports. The brokerage currently has $107.00 target price on the medical technology company’s stock, up from their prior target price of $92.00. Other equities analysts have also recently issued […]
Citigroup upgraded shares of Medtronic (NYSE:MDT – Free Report) from a neutral rating to a buy rating in a research report released on Tuesday morning, MarketBeat.com reports. The brokerage currently has $107.00 target price on the medical technology company’s stock, up from their prior target price of $92.00. Other equities analysts have also recently issued […]
